Total Payments
$136,981
2024 Payments
$6,264
Companies
62
Transactions
1,463
Medicare Patients
24,647
Medicare Billing
$3.8M
Payment Breakdown by Category
Other$93,456 (68.2%)
Food & Beverage$30,195 (22.0%)
Consulting$6,800 (5.0%)
Travel$6,122 (4.5%)
Education$409.08 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $91,806 | 40 | 67.0% |
| Food and Beverage | $30,195 | 1,346 | 22.0% |
| Consulting Fee | $6,800 | 5 | 5.0% |
| Travel and Lodging | $6,122 | 64 | 4.5% |
| Honoraria | $1,650 | 1 | 1.2% |
| Education | $409.08 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $33,223 | 100 | $0 (2024) |
| Amarin Pharma Inc. | $25,655 | 83 | $0 (2023) |
| PFIZER INC. | $18,915 | 141 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $15,258 | 55 | $0 (2024) |
| Gilead Sciences, Inc. | $13,554 | 43 | $0 (2019) |
| Aralez Pharmaceuticals US Inc. | $7,436 | 15 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $2,312 | 81 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,208 | 81 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $1,946 | 17 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $1,911 | 128 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,264 | 139 | PFIZER INC. ($3,622) |
| 2023 | $4,922 | 134 | PFIZER INC. ($2,760) |
| 2022 | $5,190 | 150 | PFIZER INC. ($2,915) |
| 2021 | $5,592 | 152 | PFIZER INC. ($2,649) |
| 2020 | $14,805 | 147 | Amarin Pharma Inc. ($6,670) |
| 2019 | $33,130 | 240 | Amarin Pharma Inc. ($18,631) |
| 2018 | $38,408 | 250 | SANOFI-AVENTIS U.S. LLC ($21,755) |
| 2017 | $28,669 | 251 | Gilead Sciences Inc ($8,194) |
All Payment Transactions
1,463 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/27/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/12/2024 | Medicure Pharma Inc. | Zypitamag (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $13.84 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: Cardiovascular | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: DIABETES | ||||||
| 10/30/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $0.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/25/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.40 | General |
| Category: Cardiovascular | ||||||
| 10/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | VivaQuant Inc, dba Rhythm Express | Rhythm Express (Device) | Food and Beverage | Cash or cash equivalent | $42.46 | General |
| Category: Remote Cardiac Monitoring | ||||||
| 09/23/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 6,830 | 12,409 | $2.5M | $1.0M |
| 2022 | 36 | 6,292 | 11,112 | $2.3M | $1.0M |
| 2021 | 31 | 5,765 | 10,561 | $2.0M | $921,514 |
| 2020 | 34 | 5,760 | 10,093 | $1.9M | $837,751 |
Total Patients
24,647
Total Services
44,175
Medicare Billing
$3.8M
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 923 | 925 | $925,000 | $390,233 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 543 | 1,525 | $359,250 | $168,369 | 46.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 463 | 472 | $234,000 | $80,387 | 34.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 314 | 320 | $128,000 | $57,835 | 45.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 934 | 939 | $187,800 | $54,629 | 29.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 923 | 1,845 | $55,350 | $44,385 | 80.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 320 | 1,271 | $50,426 | $35,505 | 70.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 170 | 171 | $68,400 | $27,393 | 40.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 559 | 1,576 | $126,080 | $21,040 | 16.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 96 | 279 | $41,850 | $20,172 | 48.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 506 | 1,204 | $36,120 | $15,783 | 43.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 39 | 218 | $76,300 | $14,997 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 54 | 61 | $18,300 | $9,946 | 54.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 12 | 12 | $24,000 | $9,209 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 95 | $14,250 | $7,502 | 52.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 46 | $13,800 | $7,383 | 53.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $12,600 | $7,079 | 56.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 91 | 93 | $9,300 | $7,034 | 75.6% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 26 | 180 | $18,000 | $4,313 | 24.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 99 | 102 | $5,100 | $3,670 | 72.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 27 | 48 | $6,000 | $3,495 | 58.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $4,800 | $3,143 | 65.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 41 | 42 | $10,500 | $2,742 | 26.1% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 351 | 617 | $6,170 | $2,375 | 38.5% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 32 | 69 | $8,625 | $1,521 | 17.6% |
About Dr. Bruce Decter, MD
Dr. Bruce Decter, MD is a Cardiovascular Disease healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114905437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Decter, MD has received a total of $136,981 in payments from pharmaceutical and medical device companies, with $6,264 received in 2024. These payments were reported across 1,463 transactions from 62 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($91,806).
As a Medicare-enrolled provider, Decter has provided services to 24,647 Medicare beneficiaries, totaling 44,175 services with total Medicare billing of $3.8M. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location New Hyde Park, NY
- Active Since 01/06/2006
- Last Updated 06/14/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1114905437
Products in Payments
- PRALUENT (Drug) $32,612
- Vascepa (Drug) $25,655
- VYNDAQEL (Drug) $14,531
- Ranexa (Drug) $13,438
- PRALUENT ALIROCUMAB INJECTION (Biological) $10,797
- YOSPRALA (Drug) $5,414
- PRALUENT (Biological) $4,350
- XARELTO (Drug) $2,312
- CONTRAVE (Drug) $2,299
- ZONTIVITY (Drug) $2,023
- ENTRESTO (Drug) $1,622
- ELIQUIS (Drug) $1,436
- JARDIANCE (Drug) $1,395
- FARXIGA (Drug) $942.60
- MULTAQ (Drug) $610.91
- Repatha (Biological) $594.17
- VERQUVO (Drug) $578.47
- Corlanor (Drug) $573.79
- Edarbi (Drug) $533.71
- LifeVest (Device) $457.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in New Hyde Park
Rajiv Jauhar, Md, MD
Cardiovascular Disease — Payments: $55,792
Cardiovascular Disease $55,792
Dr. Elias Bonaros, Md, MD
Cardiovascular Disease — Payments: $27,369
Cardiovascular Disease $27,369
Sumit Mittle, M.d, M.D
Cardiovascular Disease — Payments: $23,458
Cardiovascular Disease $23,458
Yuly Lyandres, M.d, M.D
Cardiovascular Disease — Payments: $17,731
Cardiovascular Disease $17,731
Dr. Leonardo Saulle, Md, MD
Cardiovascular Disease — Payments: $15,764
Cardiovascular Disease $15,764
Dr. Francis Kim, M.d, M.D
Cardiovascular Disease — Payments: $15,389
Cardiovascular Disease $15,389